InvestSMART

Botanix Pharmaceuticals Ltd (ASX: BOT) - Announcements

Current share price for BOT : $0.009 0.001 (10%)+

ASX company news and announcements for Botanix Pharmaceuticals Ltd (BOT) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Botanix Pharmaceuticals Ltd (BOT) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Botanix Pharmaceuticals Ltd (BOT), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Botanix Pharmaceuticals Ltd (BOT)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$25 Proposed issue of securities - BOT 2 Sep 2022 9:25AM $0.080 $0.009 fallen by 88.75%
$25 Proposed issue of securities - BOT 2 Sep 2022 9:25AM $0.080 $0.009 fallen by 88.75%
$25 Proposed issue of securities - BOT 2 Sep 2022 9:24AM $0.080 $0.009 fallen by 88.75%
$25 Botanix Completes Successful A$7.5m Placement 2 Sep 2022 9:24AM $0.080 $0.009 fallen by 88.75%
$25 Trading Halt 31 Aug 2022 9:31AM $0.080 $0.009 fallen by 88.75%
$25 Preliminary Final Report 31 Aug 2022 9:23AM $0.080 $0.009 fallen by 88.75%
$25 Quarterly activities report and Appendix 4C 29 Jul 2022 2:11PM $0.079 $0.009 fallen by 88.61%
$25 Details of Company Address 28 Jul 2022 6:05PM $0.078 $0.009 fallen by 88.46%
$25 Euroz Hartleys Healthcare Conference Presentation 27 Jul 2022 10:33AM $0.078 $0.009 fallen by 88.46%
$25 Updated Investor Presentation 12 Jul 2022 9:16AM $0.070 $0.009 fallen by 87.14%
$25 Change of Director's Interest Notice * 3 8 Jul 2022 9:45AM $0.064 $0.009 fallen by 85.94%
$25 Notice under Section 708A(5)(e) of the Corporations Act 7 Jul 2022 6:37PM $0.064 $0.009 fallen by 85.94%
$25 Application for quotation of securities - BOT 7 Jul 2022 6:32PM $0.064 $0.009 fallen by 85.94%
$25 NDA Filing Accelerated and Trials Fully Enrolled 7 Jul 2022 9:26AM $0.059 $0.009 fallen by 84.75%
$25 Investor Presentation 16 May 2022 8:44AM $0.077 $0.009 fallen by 88.31%
$25 Botanix Investor Webinar 4 May 2022 10:18AM $0.077 $0.009 fallen by 88.31%
$25 Dermatology Asset Acquired to Accelerate Path to Revenue 4 May 2022 10:12AM $0.077 $0.009 fallen by 88.31%
$25 Trading Halt 3 May 2022 9:45AM $0.077 $0.009 fallen by 88.31%
$25 Appendix 4C - Quarterly 29 Apr 2022 8:38AM $0.083 $0.009 fallen by 89.16%
$25 FDA Qualified Infectious Disease Product Status for BTX 1801 28 Apr 2022 8:40AM $0.080 $0.009 fallen by 88.68%
$25 Botanix upcoming presentation - Health Economics Conference 22 Apr 2022 8:49AM $0.079 $0.009 fallen by 88.61%
$25 Notification regarding unquoted securities - BOT 14 Apr 2022 6:50PM $0.083 $0.009 fallen by 89.16%
$25 Upcoming BTX 1801 Data Presentations at European Congress 13 Apr 2022 9:27AM $0.081 $0.009 fallen by 88.89%
$25 Experienced dermatology executives join Botanix 1 Apr 2022 8:11AM $0.087 $0.009 fallen by 89.66%
$25 Botanix receives $2.75m R&D Tax Incentive Refund 28 Mar 2022 8:22AM $0.078 $0.009 fallen by 88.46%

376 - 400 of 726 results

Page 16 of 30

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.